Although unapproved colchicine has been used for many years, FDA approved the first single-ingredient oral colchicine product, Colcrys, in July 2009 for the treatment of familial Mediterranean fever (FMF) and acute gout flares; in October 2009 Colcrys was approved for prophylaxis of gout flares (chronic gout). The approved prescribing information for Colcrys includes a new drug interaction warning, updated dosing recommendations and a medication guide. Pharmacists are reminded to dispense only FDA approved products. FDA Drug Info Rounds pharmacists discuss the differences between approved and unapproved colchicine products, concerns regarding unapproved single-ingredient oral colchicine, and how patients can offset the increased cost of Colcrys. For more information, please see our website: www.fda.gov

Doomsday cult Agape Ministries in South Australia predicts the end of the world. Devotees are collecting guns and rifles. Its leader is now on the run.

South Australia is now on election footing, even though the writs are not issued yet. Hendrik Gout reveals the plan.